Excessive sleep associated with longer time to return to work among colorectal cancer survivors

the ONA take:

Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire among colorectal cancer survivors, according to a recent study published online ahead of print in the journal Supportive Care in Cancer.

For the study, researchers in Australia enrolled 239 colorectal cancer survivors in order to assess associations of health behaviors with return to work outcomes following a colorectal cancer diagnosis among men and women aged 45 to 64 years. Participants were interviewed via telephone and answered questionnaires at 6 and 12 months following diagnosis.

Results showed that participants who reported sleeping 9 or more hours per day were 2.69 times more likely to decrease work time or retire compared with those who slept between 7 and 9 hours per day. Researchers found that excessive sleep was also associated with a longer time to returning to work.

The findings suggest that interventions designed to help colorectal cancer survivors achieve optimal sleep may help them return to work sooner. Further studies are warranted to test those interventions.

Excessive sleep associated with longer time to return to work among colorectal cancer survivors
Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire.
Engaging in positive health behaviours can improve quality of life amongst cancer survivors, whether this facilitates return to work is unknown. We examined associations of health behaviours with return to work outcomes following a diagnosis of colorectal cancer in middle-aged men and women (45-64 years).
READ FULL ARTICLE From Springer
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs